MRSN Stock Analysis: Buy, Sell, or Hold?
MRSN - Mersana Therapeutics, Inc. Common Stock
$29.08
0.04 (0.14%)
▲
5d:
+0.02%
30d:
+5.1%
90d:
+251.21%
BUY
MODERATE Confidence
Analysis Updated: Jan 5, 2026 12:00 AM ET
Get Alerted When MRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MRSN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MRSN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MRSN is currently trading at $29.08, which is considered fair based on recent price action.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
56/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading below Wall St target ($33.20)
Support & Resistance Levels
Support Level
$28.11
Resistance Level
$30.39
Current Trend
Strong Uptrend
Technical data as of
Jan 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$33.20
(+14.2%)
Revenue Growth (YoY)
-12.6%
Profit Margin
-211.2%
Share & Embed Analysis
Last updated: May 09, 2026 12:52 AM ET
Data refreshes hourly during market hours. Next update: 1:52 AM
Data refreshes hourly during market hours. Next update: 1:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$230 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
